Absolutely stunning work from a wonderful scientist!

James D Chalmers American Thoracic Society (ATS) UoD Medicine ATS PI-TB Assembly Merete Long Huge congrats to Dr. Long—what a well-deserved honor! Her work in bronchiectasis and respiratory infections is truly shaping the future of pulmonary care. #ATS2025

📅 Experts will discuss whether clinical trials should change course and begin grouping patients with cystic fibrosis and non-cystic fibrosis bronchiectasis during a must-see Tuesday session at #ATS2025. 🔗 Read more in ATS Conference News: atsconferencenews.org/ats-journals-s…

What a star. ⭐️⭐️⭐️⭐️

Asthma and Lung UK gave me a 5 year grant in 2017 that allowed us to study the idea that personalised anti-inflammatory treatment would be the way to treat bronchiectasis in future It changed my career and the careers of several young scientists I could not be more grateful 🙏🙏

On international clinical trials day we say thank you to all of the patients participating in bronchiectasis research to find new treatments and understand more about the disease #bronchiectasis EMBARC Stefano Aliberti Merete Long Holly Lind Dr. Kateryna Viligorska European Lung Foundation

Thrilled to announce exciting results of the Great2 trial of a monoclonal antibody against Pseudomonas in bronchiectasis - reduce bacterial load at day 84 - significant improvement in quality of life - reduced exacerbations Merete Long EMBARC bronchiectasis.net/clinical-trial…

Truly honored to receive this award- I’m deeply grateful to work with such an incredible and supportive team on research that makes a real difference. Thank you!

dundee.ac.uk/stories/trial-…

Can the serum antiglycopeptidolipid core IgA antibody test be used to screen for nontuberculous mycobacterial pulmonary disease in #bronchiectasis? Read the full research in the May issue of the journal CHEST®: hubs.la/Q03ndp100 #MedEd #JournalCHEST #NTMPD

Key updates on CAP treatment guidelines will be unveiled Tuesday at #ATS2025! 📅 Don't miss the session, "ATS Guidelines: Controversies in the Management of CAP and ARDS." 🔗 Learn more in ATS Conference News: atsconferencenews.org/experts-to-unv…

The eosinophiles at #ATS2025 #SanFrancisco International Eosinophil Society

45 years ago today, THE EMPIRE STRIKES BACK was released. One of the greatest movies ever made

Squeezing in one last session before the end of American Thoracic Society (ATS) Post infection complications including of course BRONCHIECTASIS! Following on from our ATS statement led by Sara Auld and Scott Evans

My 🙏 to Ajay Sheshadri, Sara Auld and Scott Evans for organizing and the other speakers James D Chalmers Yael Aschner and Assem Ziady for this awesome PIPC session to close #ATS2025

Deserved recognition for a brilliant scientist! 👏👏👏👏

That's a wrap! Thank you attendees, presenters, exhibitors, and supporters for joining us for #ATS2025. We hope you made long-lasting connections and leave feeling inspired by the latest scientific breakthroughs in pulmonary, critical care, and sleep medicine. Excited for

That’s a wrap! Thank you for attending #ATS2025! See you next year!

New at #ATS2025: Findings on brensocatib for non-cystic fibrosis bronchiectasis showed consistent efficacy as well as safety across 3 subgroups of patients. James D Chalmers gave several valuable insights on his team's data in the ASPEN trial. View 👇 🔗hcplive.com/view/subgroup-…

And that’s a wrap for a great ATS conference Highlights including a paradigm shifting discussion on bringing bronchiectasis and CF together as well as presentations by the brilliant Merete Long See you in Orlando next year!